(Q40320488)

https://doi.org/10.1016/j.ymthe.2022.12.015

19 September 2017

1 reference

29 December 2023

title

Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus (English)

1 reference

19 September 2017

1 reference

1 reference

Qinglei Gao

1

1 reference

19 September 2017

Jianfeng Zhou

2

1 reference

19 September 2017

Xiaoyuan Huang

3

1 reference

19 September 2017

Gang Chen

4

1 reference

19 September 2017

Fei Ye

5

1 reference

19 September 2017

Yunping Lu

6

1 reference

19 September 2017

Kanyan Li

7

1 reference

19 September 2017

Liang Zhuang

8

1 reference

19 September 2017

Mei Huang

9

1 reference

19 September 2017

Gang Xu

10

1 reference

19 September 2017

Shxuan Wang

11

1 reference

19 September 2017

Ding Ma

12

1 reference

19 September 2017

publication date

3 February 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

13

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

928-937

1 reference

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Exploiting novel cell cycle targets in the development of anticancer agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Multigene expression from a replicating adenovirus using native viral promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Images in clinical medicine. Liver metastases from lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Intravascular injections of a conditional replicative adenovirus (adl118) prevent metastatic disease in human breast carcinoma xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Adenoviral vectors for gene transfer and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Use of replicating oncolytic adenoviruses in combination therapy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Factors involved in the sensitivity of different hematopoietic cell lines to infection by subgroup C adenovirus: implication for gene therapy of human lymphocytic malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

PTP1B modulates the association of beta-catenin with N-cadherin through binding to an adjacent and partially overlapping target site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

New method for the analysis of cell cycle-specific apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

Nude mice model of human hepatocellular carcinoma via orthotopic implantation of histologically intact tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.12.009

The 11,600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection

7 January 2021

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.YMTHE.2005.12.009

Identifiers

DOI

10.1016/J.YMTHE.2005.12.009

1 reference

19 September 2017

1 reference